HomeCompareECTXF vs PFE

ECTXF vs PFE: Dividend Comparison 2026

ECTXF yields 1.22% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $29.7K in total portfolio value· pulled ahead in Year 9
10 years
ECTXF
ECTXF
● Live price
1.22%
Share price
$7.15
Annual div
$0.09
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$131.74
Full ECTXF calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — ECTXF vs PFE

📍 PFE pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodECTXFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ECTXF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ECTXF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ECTXF
Annual income on $10K today (after 15% tax)
$103.47/yr
After 10yr DRIP, annual income (after tax)
$111.98/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, PFE beats the other by $23,016.98/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ECTXF + PFE for your $10,000?

ECTXF: 50%PFE: 50%
100% PFE50/50100% ECTXF
Portfolio after 10yr
$36.3K
Annual income
$13,671.14/yr
Blended yield
37.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

ECTXF
No analyst data
Altman Z
3.4
Piotroski
8/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ECTXF buys
0
PFE buys
0
No recent congressional trades found for ECTXF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricECTXFPFE
Forward yield1.22%6.20%
Annual dividend / share$0.09$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$21.4K$51.1K
Annual income after 10y$131.74$27,210.54
Total dividends collected$1.3K$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ECTXF vs PFE ($10,000, DRIP)

YearECTXF PortfolioECTXF Income/yrPFE PortfolioPFE Income/yrGap
1$10,822$121.73$9,161$701.38+$1.7KECTXF
2$11,702$123.12$8,610$859.79+$3.1KECTXF
3$12,646$124.43$8,366$1,081.25+$4.3KECTXF
4$13,657$125.66$8,483$1,405.66+$5.2KECTXF
5$14,740$126.83$9,084$1,907.24+$5.7KECTXF
6$15,899$127.93$10,418$2,732.78+$5.5KECTXF
7$17,141$128.97$13,007$4,193.56+$4.1KECTXF
8$18,471$129.95$18,010$7,005.87+$461.00ECTXF
9← crossover$19,895$130.87$28,216$12,979.89$8.3KPFE
10$21,419$131.74$51,081$27,210.54$29.7KPFE

ECTXF vs PFE: Complete Analysis 2026

ECTXFStock

Electrolux Professional AB (publ) provides food service, beverage, and laundry solutions to restaurants, hotels, healthcare, educational, and other service facilities. The company operates in two segments, Food & Beverage and Laundry. It offers slicers and food processors, vegetable washers, spin dryers, planetary mixers, vacuum packers and sealers, multi-purpose peeling machines, fryers, boiling and braising pans, grills and griddles, ventilation equipment, modular cooking ranges, fry tops, combi and convection ovens, refrigerated cabinets and counters, saladettes, cold rooms, blast chillers and freezers, portable mixers, turbo liquidizers, meat mincers, dough kneaders and sheeters, salamanders, wine cellars, ice makers and flakers, and trolleys, as well as stainless steel fabrication solutions. The company also provides commercial dishwashers and accessories, waste management systems, and handling systems; cabinets, cupboards, worktables, and shelves; and coffee grinders and brewers, espresso coffee machines, coffee urns, hot and cold beverage dispensers, cold juice dispensers, beer dispensing systems, frozen granita and ice cream dispensers, soft serves, and soft ice cream dispensers. In addition, it offers front and side load washers, efficient dosing systems, barrier washers, wash and dry systems, tumble dryers, drying cabinets, semi-professional washers and dryers, ironers, industrial ironers, and finishing machines. The company operates in Europe, the Asia-Pacific, the Middle East, Africa, and the Americas. The company was incorporated in 1898 and is headquartered in Stockholm, Sweden.

Full ECTXF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this ECTXF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ECTXF vs SCHDECTXF vs JEPIECTXF vs OECTXF vs KOECTXF vs MAINECTXF vs JNJECTXF vs MRKECTXF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.